Sinopharm
1099.HK
#2290
Rank
โ‚น775.61 B
Marketcap
โ‚น248.54
Share price
-0.76%
Change (1 day)
30.48%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Revenue for Sinopharm (1099.HK)

Revenue in 2024: โ‚น7.452 Trillion

According to Sinopharm's latest financial reports the company's current revenue (TTM ) is โ‚น7.452 Trillion. In 2024 the company made a revenue of โ‚น7.452 Trillion a decrease over the revenue in the year 2023 that were of โ‚น7.852 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sinopharm from 2006 to 2024

Annual revenue

Year Revenue Change
2024โ‚น7.452 T-5.1%
2023โ‚น7.852 T5.42%
2022โ‚น7.449 T-2.1%
2021โ‚น7.608 T16.85%
2020โ‚น6.511 T14.95%
2019โ‚น5.664 T21.52%
2018โ‚น4.661 T5.93%
2017โ‚น4.400 T27.22%
2016โ‚น3.458 T5.37%
2015โ‚น3.282 T9.14%
2014โ‚น3.007 T17.22%
2013โ‚น2.565 T25.94%
2012โ‚น2.037 T34.61%
2011โ‚น1.513 T55.34%
2010โ‚น974.23 B35.79%
2009โ‚น717.46 B37.56%
2008โ‚น521.57 B31.43%
2007โ‚น396.86 B40.26%
2006โ‚น282.94 B